SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

24 Apr 2025 Evaluate
A decent increase of about 28.00% in the sales to Rs. 0.96 millions was observed for the quarter ended March 2025. The sales figure stood at Rs. 0.75 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -0.67 millions as compared to Net Profit of Rs. 2.70 millions of corresponding quarter ended March 2024Operating profit surged to 2.85 millions from the corresponding previous quarter of 0.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.96 0.75 28.00 6.11 5.55 10.09 6.11 5.55 10.09
Other Income 6.08 4.84 25.62 20.09 19.92 0.85 20.09 19.92 0.85
PBIDT 2.85 0.91 213.19 10.58 9.10 16.26 10.58 9.10 16.26
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 2.84 0.91 212.09 10.57 9.10 16.15 10.57 9.10 16.15
Depreciation 0.24 0.24 0.00 0.98 0.98 0.00 0.98 0.98 0.00
PBT 2.60 0.67 288.06 9.59 8.12 18.10 9.59 8.12 18.10
TAX 3.27 -2.03 -261.08 6.42 1.62 296.30 6.42 1.62 296.30
Deferred Tax -0.08 0.00 0.00 2.02 1.49 35.57 2.02 1.49 35.57
PAT -0.67 2.70 -124.81 3.17 6.50 -51.23 3.17 6.50 -51.23
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 296.88 121.33 144.68 173.16 163.96 5.61 173.16 163.96 5.61

Emmessar Biotech&Nut Share Price

26.86 1.06 (4.11%)
16-Apr-2026 12:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.40
Dr. Reddys Lab 1223.00
Cipla 1230.60
Zydus Lifesciences 936.35
Lupin 2300.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×